Survey: Three-in-four Americans want access to pseudoephedrine
WASHINGTON – Almost three-in-four Americans want to maintain access to medicines containing pseudoephedrine, according to an Asthma and Allergy Foundation of America survey that encompassed five states in the middle of the U.S.
“The survey results are evidence that patients who need access to these medicines feel very strongly about access,” said Meryl Bloomrosen, AAFA’s SVP advocacy, policy and research. “A few states and localities have taken steps to impede people suffering from cough, cold and allergies from easily accessing the safe and effective FDA-approved therapies they rely on, and these places are greatly inconveniencing consumers.”
Across the five states, the survey found that among those using non-prescription medications to treat one or more condition:
- 98% who experienced cold, cough and flu symptoms, and 88% of those living with nasal allergies, purchase non-prescription medication to treat their ailments;
- 65% of those experiencing cold, cough, flu symptoms or nasal allergies would choose a decongestant based on a trusted brand that has previously worked for them rather than the one with the lower price;
- 92% of those experiencing cold, cough, flu symptoms or nasal allergies feel it is important that their full-service pharmacy offer all of the safe and effective medications available on the market, including 84% who say a full spectrum of medications available is important even if they are not currently using them;
- 71% of those experiencing cold, cough, flu symptoms or nasal allergies say that they somewhat or very unfavorably view pharmacies that remove medications containing PSE; and
- 80% of those experiencing cold, cough, flu symptoms or nasal allergies say that they would feel somewhat or very unfavorably if they need to travel to more than one retail location to purchase all of the medications they need for themselves or their family.
The survey, conducted online for AAFA by Harris Poll Jan. 14 through 26, included 2,027 users of non-prescription medicine used to treat nasal allergies, asthma and/or cold, cough or flu in Illinois, Indiana, Oklahoma, Tennessee and Missouri.
Nordic Naturals pledges $25,000 to Big Brothers Big Sisters of America
WATSONVILLE Calif. – Nordic Naturals earlier this month kicked off the back-to-school season with its “One + One = More” campaign to benefit Big Brothers Big Sisters of America, a nationwide non-profit organization that serves children ages 6 through 18.
From July through September 2015, every time a consumer purchases a bottle of Nordic Naturals children’s products, the company will donate $1 to the life-changing work of BBBS, for a total contribution of up to $25,000.
“Each year, as the back-to-school season approaches, we look for an organization that shares our passion for giving each generation what they need to grow healthy and strong,” said Joar Opheim, CEO of Nordic Naturals. “This year, we are pleased to support Big Brothers Big Sisters and their mentoring programs that help children realize their potential and build healthy futures.”
In addition, Nordic Naturals employees will support the campaign through “Build-a-Backpack Day” with BBBS at the company’s corporate headquarters here. This interactive activity for the Bigs, the Littles and the Nordic Naturals staff will provide backpacks for the start of the school year. And Nordic Naturals will host a Facebook contest in August — “Mentor 4 Change” — to help raise awareness about this organization.
AARP unveils 7 ways to improve sleep trackers for boomers
WASHINGTON – The design and utility of today's sleep trackers aren't meeting the expectations of the 50-plus population, according to an AARP study released Tuesday, suggesting a significant opportunity for the first company that develops a boomer-friendly sleep tracker.
Georgia Tech Research Institute's HomeLab in partnership with the recently launched Project Catalyst: The Power of We initiative, a program that encourages tech developers to design toward the 50-plus demographics' desire for longevity and wellness, gave 92 older consumers one of seven popular devices to use at home for six weeks in their daily lives. At the end of the six-week trial:
- 71% of participants reported increased awareness of activity, sleep or eating habits;
- 45% reported increased motivation;
- 46% said they changed their behavior; and
- 67% of participants reported the activity and sleep tracker to be beneficial or of value.
"Despite what some people may think, the study showed that consumers in the 50-plus age group enjoy interacting with technology when it provides them with constructive and usable feedback on their goals," said Brad Fain, a director of Georgia Tech's HomeLab and principal research scientist at the Georgia Tech Research Institute. "They are motivated to use new products that help them achieve good health and avoid illness – important findings as we seek to improve technology and make life easier for this underserved population."
The study, "Building a Better Tracker: Older Consumers Weigh in On Activity and Sleep Monitoring Devices" is the first of several health technology studies under the Project Catalyst initiative that AARP will conduct and report on as part of its effort to accelerate innovation for aging Americans. With the support of MedStar Health, Pfizer and UnitedHealthcare, this initiative seeks to identify ways to improve products and services for the 50-plus population – who today are the largest consumers of healthcare.
With regard to how future activity and sleep trackers can be improved for consumers in the 50-plus age range, the study confirmed that the success of the next generation of trackers is directly correlated to their ease of use and their effectiveness.
"The recommendations that came out of the study are to make trackers better able to share information on health goals important to 50-plus consumers, simplify set up, make them unobtrusive to wear and easier to maintain, and provide more features like timely alerts and instantaneous access to information," said Jody Holtzman, AARP SVP Thought Leadership. "If these qualities are prioritized, the potential in the 50-plus market for activity and sleep trackers is likely to grow."
Other specific recommendations from the study's participants included:
- Providing detailed, easy-to-understand instructions;
- Providing an explanation of how activity and sleep trackers collect data;
- Ensuring robust syncing capabilities;
- Ensuring comfort while wearing the tracker;
- Enabling timely notifications targeted to 50-plus consumers;
- Providing a display for instant information access; and
- Incorporating additional sensors related to health-specific conditions.
The next Project Catalyst study is already underway at the Georgia Tech's HomeLab and looks at medication management tools designed to help people take their medicine on time and as prescribed.
Loading Post Please Wait...